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 BACKGROUND: 
Oral squamous cell carcinoma (OSCC) is the most frequent malignant tumour 
of the oral cavity. It is accepted that screening for oral squamous cell carcinomas and 
oral premalignant lesions may decrease the devastating morbidity and mortality 
associated with the disease. This has lead to widespread research for identification of 
molecular based bio-markers. Among them survivin is a recently characterised IAP 
protein which is a member of the inhibitor of apoptosis family.
 
Further investigation 
of survivin during tumour growth and progression may yield important insights into 
its functional role in carcinogenesis. 
OBJECTIVES:  
 To compare the expression of survivin in oral epithelial dysplasias and oral 
squamous cell carcinoma with that in normal mucosa. 
MATERIALS AND METHODS: 
Study subjects consisted of formalin fixed paraffin embedded blocks of 
histologically confirmed cases of oral epithelial dysplasia (n=30), oral squamous cell 
carcinoma (OSCC) (n=30) and normal mucosa (n=30) in the age group of 20-70 
years.  Immunohistochemical staining was performed on 4µm sections of paraffin 
embedded sections with the use of survivin rabbit monoclonal antibody (PathnSitu).  
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 RESULTS: 
There was statistical significance between the expression of survivin 
among oral epithelial dysplasia, oral squamous cell carcinoma and normal 
mucosa with a p value of 0.001 (Kruskal-Wallis test significant at 0.01 level).  
INTEPRETATION AND CONCLUSION:  
Results showed that there is significant up regulation of survivin expression in 
oral epithelial dysplasias and oral squamous cell carcinoma when compared to that in 
normal mucosa. It is concluded that survivin which is an inhibitor of apoptosis protein 
can be identified as a useful tool for the identification of precancerous lesions at 
higher risk for progression into invasive carcinoma. 
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